Robin Gunn
About Robin Gunn
Robin Gunn serves as the Director of Structural Biology at Mirati Therapeutics, bringing over 20 years of experience in protein expression and purification. He has held various positions in notable institutions, including The Scripps Research Institute and Ambrx, and has expertise in x-ray crystallography and high-throughput screening.
Current Role at Mirati Therapeutics
Robin Gunn currently serves as the Director of Structural Biology at Mirati Therapeutics, a position held since 2022. In this role, Gunn focuses on advancing the understanding of protein structures to facilitate drug discovery and development. The work involves leading a team dedicated to structural biology initiatives that support therapeutic projects.
Previous Experience in Structural Biology
Prior to joining Mirati Therapeutics, Robin Gunn held the position of Senior Principal Scientist at the same company from 2019 to 2022. Before that, Gunn worked at The Scripps Research Institute in various roles, including Senior Research Associate and Post Doctoral Scientist, accumulating significant experience in protein expression and purification over a span of six years.
Educational Background
Robin Gunn earned a Bachelor of Science degree in Chemistry from Harvey Mudd College, where studies were completed from 1991 to 1995. Following this, Gunn pursued a PhD in Biochemistry at The Scripps Research Institute, which took place from 1995 to 2002. This educational foundation laid the groundwork for a career focused on structural biology and protein engineering.
Expertise in Protein Engineering
With over 20 years of experience, Robin Gunn has developed expertise in x-ray crystallography and high-throughput screening. Gunn specializes in construct design and fragment screening, which are critical components in the field of structural biology and drug discovery. This expertise is leveraged in both research and development settings.
Career Timeline and Key Positions
Robin Gunn's career includes various significant positions. From 2013 to 2014, Gunn worked as a Consultant at Ambrx in the Greater San Diego Area. Prior to that, Gunn was a Structural Biologist and Protein Engineer at Scientific Consultant from 2018 to 2019. Additionally, Gunn has experience as a Graduate Student and Post Doctoral Research Fellow at The Scripps Research Institute, contributing to a robust professional background.